当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:278.02亿  总市值:423.82亿
流通股本:5.67亿   总股本:8.65亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金4,856,126,172.223,056,322,442.941,476,940,313.676,804,043,814.92
收到的税费返还2,149,719.161,183,047.88605,373.19,955,470.41
收到其他与经营活动有关的现金135,443,635.26109,908,791.0872,181,130.59281,306,124.09
经营活动现金流入的平衡项目0000
经营活动现金流入小计4,993,719,526.643,167,414,281.91,549,726,817.367,095,305,409.42
购买商品、接受劳务支付的现金1,378,495,566.27848,583,328.12424,620,458.162,048,085,771.45
支付给职工以及为职工支付的现金2,298,577,074.561,609,200,179.32715,041,330.92,930,923,401.17
支付的各项税费436,973,562.51323,762,293.83156,787,118.65654,870,188.18
支付其他与经营活动有关的现金300,903,713.35208,540,095.92109,073,449.58310,988,106.57
经营活动现金流出的平衡项目0000
经营活动现金流出小计4,414,949,916.692,990,085,897.191,405,522,357.295,944,867,467.37
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额578,769,609.95177,328,384.71144,204,460.071,150,437,942.05
二、投资活动产生的现金流量:
收回投资收到的现金619,025,446.77286,899,076.47152,158,471.611,173,925,795.56
取得投资收益收到的现金33,510,950.6913,078,605.8710,191,108.3343,440,432.88
处置固定资产、无形资产和其他长期资产收回的现金净额188,383.44128,657.76241,787.695,312,645.89
收到的其他与投资活动有关的现金14,687,103.1513,835,699.6556,169.7171,215,099.72
投资活动现金流入的平衡项目0000
投资活动现金流入小计667,411,884.05313,942,039.75162,647,537.341,293,893,974.05
购建固定资产、无形资产和其他长期资产支付的现金278,061,741.81202,262,777.11111,541,968.02313,756,832.07
投资支付的现金6,091,185,860.34,733,489,965.34170,501,193.432,142,064,124.64
取得子公司及其他营业单位支付的现金20,964,321.47--356,929,561.84
支付其他与投资活动有关的现金316,860-320,94015,368,197.97
投资活动现金流出的平衡项目0000
投资活动现金流出小计6,390,528,783.584,935,752,742.45282,364,101.452,828,118,716.52
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-5,723,116,899.53-4,621,810,702.7-119,716,564.11-1,534,224,742.47
三、筹资活动产生的现金流量:
吸收投资收到的现金61,900,00031,300,00021,300,000385,833,621.33
其中:子公司吸收少数股东投资收到的现金-31,300,000--
取得借款收到的现金2,843,516,597.921,515,318,400373,008,0003,200,523,134.86
收到其他与筹资活动有关的现金107,255,379.2954,500,229.0653,195,471.279,711,772.88
筹资活动现金流入平衡项目0000
筹资活动现金流入小计3,012,671,977.211,601,118,629.06447,503,471.273,596,068,529.07
偿还债务支付的现金2,035,406,823.68742,705,523.5182,896,9602,516,748,688.43
分配股利、利润或偿付利息支付的现金608,854,337.0383,954,901.9830,264,550.62589,866,946.69
其中:子公司支付给少数股东的股利、利润-19,797,431.75--
支付其他与筹资活动有关的现金640,412,502.45568,248,193.06331,917,188.68497,258,954.23
筹资活动现金流出平衡项目0000
筹资活动现金流出小计3,284,673,663.161,394,908,618.55445,078,699.33,603,874,589.35
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-272,001,685.95206,210,010.512,424,771.97-7,806,060.28
四、汇率变动对现金及现金等价物的影响-21,705,538.241,473,866.18-5,074,061.178,793,343.53
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-5,438,054,513.77-4,236,798,441.321,838,606.76-382,799,517.17
加:期初现金及现金等价物余额7,399,941,369.857,399,941,369.857,399,941,369.857,782,740,887.02
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,961,886,856.083,163,142,928.557,421,779,976.617,399,941,369.85
补充资料:
净利润-557,578,693.92-2,149,926,843.57
资产减值准备-36,083,691.56-68,098,216
固定资产和投资性房地产折旧-56,349,034.77-110,881,103.36
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-56,349,034.77-110,881,103.36
无形资产摊销-44,831,032.73-74,175,980.91
长期待摊费用摊销-19,900,452.34-33,337,538.65
处置固定资产、无形资产和其他长期资产的损失--1,489,722.71-188,092.67
公允价值变动损失-98,403,141.06--352,770,634.28
财务费用-52,808,964.67-117,288,062.72
投资损失--70,743,456.58--338,175,307.12
递延所得税-6,199,820.03--13,852,564.68
其中:递延所得税资产减少-11,465,967.19--13,438,174.12
递延所得税负债增加--5,266,147.16--414,390.56
存货的减少-1,260,726.4--4,364,957.26
经营性应收项目的减少--585,332,527.34--719,465,431.86
经营性应付项目的增加--145,795,782.17--111,549,453.91
其他-47,982,352.97-16,092,085.98
现金的期末余额-3,163,142,928.55-7,399,941,369.85
减:现金的期初余额-7,399,941,369.85-7,782,740,887.02
公告日期2024-10-302024-08-292024-04-262024-03-29
审计意见(境内)标准无保留意见
TOP↑